These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15980370)

  • 1. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.
    Giannoni F; Iona E; Sementilli F; Brunori L; Pardini M; Migliori GB; Orefici G; Fattorini L
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2928-33. PubMed ID: 15980370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
    Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
    Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.
    Arjomandzadegan M; Titov L; Farnia P; Owlia P; Ranjbar R; Sheikholeslami F; Surkova L
    Int J Mycobacteriol; 2016 Sep; 5(3):299-305. PubMed ID: 27847014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
    Cheng AF; Yew WW; Chan EW; Chin ML; Hui MM; Chan RC
    Antimicrob Agents Chemother; 2004 Feb; 48(2):596-601. PubMed ID: 14742214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.
    Luo T; Yuan J; Peng X; Yang G; Mi Y; Sun C; Wang C; Zhang C; Bao L
    J Antimicrob Chemother; 2017 Jul; 72(7):1893-1900. PubMed ID: 28387828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates.
    Singh M; Jadaun GP; Ramdas ; Srivastava K; Chauhan V; Mishra R; Gupta K; Nair S; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    Indian J Med Res; 2011 May; 133(5):535-40. PubMed ID: 21623040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis.
    Ando H; Mitarai S; Kondo Y; Suetake T; Kato S; Mori T; Kirikae T
    J Med Microbiol; 2011 Feb; 60(Pt 2):184-188. PubMed ID: 21051549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic detection of fluoroquinolone resistance in drug-resistant Mycobacterium tuberculosis at a tertiary care centre in south Coastal Karnataka, India.
    Chawla K; Kumar A; Shenoy VP; Chakrabarty S; Satyamoorthy K
    J Glob Antimicrob Resist; 2018 Jun; 13():250-253. PubMed ID: 29421317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
    Avalos E; Catanzaro D; Catanzaro A; Ganiats T; Brodine S; Alcaraz J; Rodwell T
    PLoS One; 2015; 10(3):e0120470. PubMed ID: 25816236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
    Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A
    Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Specific
    Singh PK; Singh U; Jain A
    Microb Drug Resist; 2021 May; 27(5):647-651. PubMed ID: 32991238
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India.
    Sulochana S; Narayanan S; Paramasivan CN; Suganthi C; Narayanan PR
    J Chemother; 2007 Apr; 19(2):166-71. PubMed ID: 17434825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
    Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
    Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
    Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of drug resistance to ofloxacin and kanamycin in Mycobacterium tuberculosis by using multiplex allele-specific PCR.
    Kumari R; Banerjee T; Anupurba S
    J Infect Public Health; 2018; 11(1):54-58. PubMed ID: 28404233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
    Von Groll A; Martin A; Jureen P; Hoffner S; Vandamme P; Portaels F; Palomino JC; da Silva PA
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4498-500. PubMed ID: 19687244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR.
    van Doorn HR; An DD; de Jong MD; Lan NT; Hoa DV; Quy HT; Chau NV; Duy PM; Tho DQ; Chinh NT; Farrar JJ; Caws M
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):736-42. PubMed ID: 18544197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.